Back to Journals » Drug Design, Development and Therapy » Volume 11

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials

Total article views   Abstract views HTML views PDF downloads Totals
6,677 Dovepress* 5,488 685+ 667 6,173
PubMed Central* 0 504 161 504
Totals 5,488 1,189 828 6,677
*Since 7 November 2017
+Since July 2016

View citations on PubMed Central and Google Scholar